Identifying and definitional attributes | |
Metadata item type: | Indicator |
---|---|
Indicator type: | Progress measure |
Short name: | PI 15–Effective management of diabetes, 2022 |
METEOR identifier: | 740866 |
Registration status: | Health!, Standard 24/09/2021 |
Description: | Proportion of people with known diabetes who have an HbA1c (glycated haemoglobin) level less than or equal to 7.0% |
Indicator set: | National Healthcare Agreement (2022) Health!, Standard 24/09/2021 |
Outcome area: | Primary and Community Health Health!, Standard 07/07/2010 |
Collection and usage attributes | |
Population group age from: | 18 years |
---|---|
Population group age to: | 69 years |
Computation description: | The National Health Measures Survey component of the 2011–13 Australian Health Survey included a fasting plasma glucose test. For this indicator, the fasting plasma glucose test is used in the determination of people with known diabetes and the HbA1c test is used in the determination of effective management of diabetes. Persons with known diabetes who have an HbA1c result of less than or equal to 7.0% are considered to be managing their diabetes effectively. Known diabetes is defined as persons self-reporting that they had ever been told by a doctor or nurse that they have diabetes and:
Excludes persons who did not fast for 8 hours or more prior to their blood test. Excludes women with gestational diabetes. Reported for persons aged between 18 and 69. Analysis by remoteness and Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage (IRSD) is based on usual residence of the person (subject to data availability). Presented as a percentage. 95% confidence intervals and relative standard errors are calculated for rates. |
Computation: | Crude rate: 100 x (Numerator ÷ Denominator) |
Numerator: | Number of persons aged between 18 and 69 with known diabetes, as determined by a fasting plasma glucose test, who have an HbA1c level of less than or equal to 7.0%. |
Numerator data elements: |
|
Denominator: | Number of persons aged between 18 and 69 with known diabetes, as determined by a fasting plasma glucose test. |
Denominator data elements: |
|
Disaggregation: | State and territory, by:
Nationally, by (all not reported this cycle):
Some disaggregation may result in numbers too small for publication. |
Disaggregation data elements: |
|
Comments: | Most recent data available for 2022 National Healthcare Agreement performance reporting: 2011–12 (total population, non-Indigenous: AHS); 2012–13 (Indigenous only: AATSIHS). NO NEW DATA FOR 2022 REPORTING. Data for the Northern Territory should be interpreted with caution as the Australian Health Survey excluded discrete Aboriginal and Torres Strait Islander communities and very remote areas, which comprise around 30% of the estimated resident population of the Northern Territory living in private dwellings. Further details on effective management of diabetes among Indigenous Australians are available from the Aboriginal and Torres Strait Islander Health Performance Framework (measure 1.09: Diabetes and measure 3.05: Chronic disease management). |
Representational attributes | |
Representation class: | Percentage |
Data type: | Real |
Unit of measure: | Person |
Format: | N[NN].N |
Indicator conceptual framework | |
Framework and dimensions: | Effectiveness |
Data source attributes | |
Data sources: | |
Accountability attributes | |
Reporting requirements: | National Healthcare Agreement |
Organisation responsible for providing data: | Australian Bureau of Statistics |
Further data development / collection required: | Specification: Final, the measure meets the intention of the indicator. |
Source and reference attributes | |
Reference documents: | Australian Bureau of Statistics (ABS) (Reference period: 2011–12). Australian Health Survey: Biomedical Results for Chronic Diseases, 2011–12. ABS Website. Viewed 22 February 2021, https://www.abs.gov.au/statistics/health/health-conditions-and-risks/australian-health-survey-biomedical-results-chronic-diseases/latest-release Australian Institute of Health and Welfare (AIHW) 2020. Aboriginal and Torres Strait Islander Health Performance Framework. Canberra: AIHW. Viewed 19 February 2021, https://indigenoushpf.gov.au/ |
Relational attributes | |
Related metadata references: | Supersedes National Healthcare Agreement: PI 15–Effective management of diabetes, 2021 Health!, Standard 03/07/2020 See also National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2022 Health!, Standard 24/09/2021 See also National Healthcare Agreement: PI 10–Prevalence of Type 2 diabetes, 2022 Health!, Standard 24/09/2021 |